Business

Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities

New manufacturing capacity allows Establishment Labs to provide over half the current world demand for breast implants and supports upcoming launches in

articleEstablishment Labs Holdings Inc.July 19, 20235/company/establishment-labs-holdings-inc/news/establishment-labs-celebrates-opening-of-sulayom-innovation-campus-and-outlines-new
Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities

About this update from Establishment Labs Holdings Inc.

[{"type":"text","content":"\n\nNew manufacturing capacity allows Establishment Labs to provide over half the current world demand for breast implants and supports upcoming launches in China and the U.S.\n\n\n\nGlobal Learning Center expands training in next generation technologies\n\n\n\nEstablishment Labs also publishes 2022 Sustainability Review\n\n\n\n NEW YORK--(BUSINESS WIRE)--\nEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the grand opening of the Sulàyöm Innovation Campus in the Coyol Free Zone, Costa Rica.\n\n\nThe Sulàyöm Campus will support Establishment Labs’ continued global growth with additional capacity and capabilities in manufacturing, R&D, digital media, training, and medical education. The first phase of the project, which opens today, includes approximately 100,000 square feet of manufacturing, medical, research, and office space. The added manufacturing more than doubles Establishment Labs’ capacity, allowing the company to provide over half the current world demand for breast implants.\n\n\n“To the Bribri, an indigenous tribe in Costa Rica, the Sulàyöm mountain is regarded as the center of all creation. We chose to name our innovation campus Sulàyöm as a reminder of our heritage and of our unwavering commitment to women around the world,” said Juan José Chacón-Quirós, CEO and Founder of Establishment Labs. “Today, on the fifth anniversary of Establishment Labs’ public listing, we are scaling-up our company to support the growing demand for our products globally, including them being made available in the U.S. and China; the creation of a new category with Mia Femtech; and our commitment to expand access globally to high quality breast reconstruction.”\n\n\nThe new facilities also include advanced R&D labs, new media production and broadcasting studios, executive offices and meeting facilities, and a Global Learning Center, which includes a surgical theatre and procedure rooms for medical education and training. The campus includes an additional 45,000 square feet of space that can be used to further expand manufacturing or other capabilities. The state-of-the-art facility is designed to be carbon neutral and uses sustainable materials and other green design elements and standa...

More updates from Establishment Labs Holdings Inc.